F. Bray, A. Jemal, N. Grey, J. Ferlay, and D. Forman, Global cancer transitions according to the Human Development Index (2008?2030): a population-based study, The Lancet Oncology, vol.13, issue.8, pp.790-801, 2012.

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians, vol.68, issue.6, pp.394-424, 2018.

F. Mégraud, E. Bessède, and C. Varon, Helicobacter pylori infection and gastric carcinoma, Clinical Microbiology and Infection, vol.21, issue.11, pp.984-990, 2015.

C. A. González, F. Megraud, A. Buissonniere, L. Lujan-barroso, A. Agudo et al., Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project, Annals of Oncology, vol.23, issue.5, pp.1320-1324, 2012.

P. Correa and J. Houghton, Carcinogenesis of Helicobacter pylori, Gastroenterology, vol.133, issue.2, pp.659-672, 2007.

S. Backert and M. Selbach, Role of type IV secretion inHelicobacter pyloripathogenesis, Cellular Microbiology, vol.10, issue.8, pp.1573-1581, 2008.

M. R. Amieva, R. Vogelmann, A. Covacci, L. S. Tompkins, W. J. Nelson et al., Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA, Science, vol.300, issue.5624, pp.1430-1434, 2003.

J. Baud, C. Varon, S. Chabas, L. Chambonnier, F. Darfeuille et al., Helicobacter pylori Initiates a Mesenchymal Transition through ZEB1 in Gastric Epithelial Cells, PLoS ONE, vol.8, issue.4, p.e60315, 2013.

M. S. Marques, J. Melo, B. Cavadas, N. Mendes, L. Pereira et al., Afadin Downregulation by Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Gastric Cells, Frontiers in Microbiology, vol.9, p.2712, 2018.

Y. Yin, A. M. Grabowska, P. A. Clarke, E. Whelband, K. Robinson et al., Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7, Gut, vol.59, issue.8, pp.1037-1045, 2010.

J. P. Thiery, H. Acloque, R. Y. Huang, and M. A. Nieto, Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-890, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02912716

E. Bessède, S. Molina, L. A. Amador, P. Dubus, C. Staedel et al., Deletion of IQGAP1 promotes Helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro, Oncotarget, vol.7, issue.49, pp.80688-80699, 2016.

E. Bessède, C. Staedel, L. A. Acuña-amador, P. H. Nguyen, L. Chambonnier et al., Helicobacter pylori generates cells with cancer stem cell properties via epithelial?mesenchymal transition-like changes, Oncogene, vol.33, issue.32, pp.4123-4131, 2013.

S. A. Mani, W. Guo, M. Liao, E. N. Eaton, A. Ayyanan et al., The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-715, 2008.

P. H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop et al., Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clinical Cancer Research, vol.23, issue.6, pp.1586-1597, 2016.

W. Chen, X. Zhang, C. Chu, W. L. Cheung, L. Ng et al., Identification of CD44+ cancer stem cells in human gastric cancer, Hepatogastroenterology, vol.60, pp.949-954, 2013.

S. Takaishi, T. Okumura, S. Tu, S. S. Wang, W. Shibata et al., Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44, Stem Cells, vol.27, issue.5, pp.1006-1020, 2009.

K. Fukuda, Y. Saikawa, M. Ohashi, K. Kumagai, M. Kitajima et al., Tumor initiating potential of side population cells in human gastric cancer, Int. J. Oncol, vol.34, pp.1201-1207, 2009.

W. M. Lau, E. Teng, H. S. Chong, K. A. Lopez, A. Y. Tay et al., CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells, Cancer Research, vol.74, issue.9, pp.2630-2641, 2014.

P. H. Nguyen, J. Giraud, C. Staedel, L. Chambonnier, P. Dubus et al., All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene, vol.35, issue.43, pp.5619-5628, 2016.

S. Courtois, R. V. Durán, J. Giraud, E. Sifré, J. Izotte et al., Metformin targets gastric cancer stem cells, European Journal of Cancer, vol.84, pp.193-201, 2017.

F. Yu, B. Zhao, and K. Guan, Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer, Cell, vol.163, issue.4, pp.811-828, 2015.

H. D. Huh, D. H. Kim, H. Jeong, and H. W. Park, Regulation of TEAD Transcription Factors in Cancer Biology, Cells, vol.8, issue.6, p.600, 2019.

P. C. Calses, J. J. Crawford, J. R. Lill, and A. Dey, Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities, Trends in Cancer, vol.5, issue.5, pp.297-307, 2019.

S. Piccolo, S. Dupont, and M. Cordenonsi, The Biology of YAP/TAZ: Hippo Signaling and Beyond, Physiological Reviews, vol.94, issue.4, pp.1287-1312, 2014.

F. Zanconato, M. Cordenonsi, and S. Piccolo, YAP/TAZ at the Roots of Cancer, Cancer Cell, vol.29, issue.6, pp.783-803, 2016.

C. G. Hansen, T. Moroishi, and K. Guan, YAP and TAZ: a nexus for Hippo signaling and beyond, Trends in Cell Biology, vol.25, issue.9, pp.499-513, 2015.

B. Zhao, L. Li, Q. Lei, and K. L. Guan, The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version, Genes & Development, vol.24, issue.9, pp.862-874, 2010.

R. Johnson and G. Halder, The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment, Nature Reviews Drug Discovery, vol.13, issue.1, pp.63-79, 2013.

S. E. Molina-castro, C. Tiffon, J. Giraud, H. Boeuf, E. Sifre et al., The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa, Cellular and Molecular Gastroenterology and Hepatology, vol.9, issue.2, pp.257-276, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-03004849

W. Kang, J. H. Tong, A. W. Chan, T. Lee, R. W. Lung et al., Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor Prognosis, Clinical Cancer Research, vol.17, issue.8, pp.2130-2139, 2011.

M. Song, J. Cheong, H. Kim, S. H. Noh, and H. Kim, Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer, Anticancer Res, vol.32, pp.3827-3834, 2012.

L. Yu, C. Gao, B. Feng, L. Wang, X. Tian et al., Distinct prognostic values of YAP1 in gastric cancer, Tumour. Biol, 2017.

M. Cordenonsi, F. Zanconato, L. Azzolin, M. Forcato, A. Rosato et al., The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells, Cell, vol.147, pp.759-772, 2011.

M. Bartucci, R. Dattilo, C. Moriconi, A. Pagliuca, M. Mottolese et al., TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells, Oncogene, vol.34, pp.681-690, 2015.

Z. Li, Y. Wang, Y. Zhu, C. Yuan, D. Wang et al., The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer, Mol. Oncol, vol.9, pp.1091-1105, 2015.

D. Xie, J. Cui, T. Xia, Z. Jia, L. Wang et al., Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression, Oncotarget, vol.6, pp.35949-35963, 2015.

H. Yuen, C. M. Mccrudden, Y. Huang, J. M. Tham, X. Zhang et al., TAZ expression as a prognostic indicator in colorectal cancer, PLoS ONE, vol.8, 2013.

J. Hong, E. S. Hwang, M. T. Mcmanus, A. Amsterdam, Y. Tian et al., TAZ, a transcriptional modulator of mesenchymal stem cell differentiation, Science, vol.309, pp.1074-1078, 2005.

J. Wei, L. Wang, J. Zhu, A. Sun, G. Yu et al., The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma, Cancer Cell Int, vol.19, 2019.

G. Yue, X. Sun, A. Gimenez-capitan, J. Shen, L. Yu et al., TAZ is highly expressed in gastric signet ring cell carcinoma, Biomed. Res. Int, vol.393064, 2014.

L. Ge, D. Li, F. Chen, J. Feng, B. Li et al., TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells, International Journal of Oncology, vol.51, issue.1, pp.307-315, 2017.

J. Giraud, S. Molina-castro, L. Seeneevassen, E. Sifré, J. Izotte et al., Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells, Int. J. Cancer, vol.146, pp.2255-2267, 2020.

G. Zhou, X. Li, Q. Zhang, K. Zhao, C. Zhang et al., Effects of the hippo signaling pathway in human gastric cancer. Asian Pac, J. Cancer Prev, vol.14, pp.5199-5205, 2013.

J. Giraud, D. Bouriez, L. Seeneevassen, B. Rousseau, E. Sifré et al., Orthotopic patient-derived xenografts of gastric cancer to decipher drugs effects on cancer stem cells and metastatic dissemination, Cancers

C. Varon, P. Dubus, F. Mazurier, C. Asencio, L. Chambonnier et al., Helicobacter pylori Infection Recruits Bone Marrow?Derived Cells That Participate in Gastric Preneoplasia in Mice, Gastroenterology, vol.142, issue.2, pp.281-291, 2012.

L. Azzolin, T. Panciera, S. Soligo, E. Enzo, S. Bicciato et al., YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response, Cell, vol.158, pp.157-170, 2014.

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., An open-source platform for biological-image analysis, Nat. Methods, vol.9, pp.676-682, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02616466

S. Odenbreit, J. Püls, B. Sedlmaier, E. Gerland, W. Fischer et al., Translocation of helicobacter pylori CagA into gastric epithelial cells by type IV secretion, Science, vol.287, pp.1497-1500, 2000.

Y. Wu, L. Shen, X. Liang, S. Li, L. Ma et al., Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1? expression, Cancer Med, vol.8, pp.3965-3980, 2019.

N. Li, Y. Feng, Y. Hu, C. He, C. Xie et al., Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway, J. Exp. Clin. Cancer Res, vol.37, 2018.

J. Wei, G. Yu, G. Shao, A. Sun, M. Chen et al., CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma, Oncotarget, vol.7, pp.31067-31078, 2016.

E. Bessède, P. Dubus, F. Mégraud, and C. Varon, Helicobacter pylori infection and stem cells at the origin of gastric cancer, Oncogene, vol.34, issue.20, pp.2547-2555, 2014.

V. G. Weis and J. R. Goldenring, Current understanding of SPEM and its standing in the preneoplastic process, Gastric Cancer, vol.12, pp.189-197, 2009.

C. Belair, J. Baud, S. Chabas, C. M. Sharma, J. Vogel et al., Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression, Silence, vol.2, issue.1, p.7, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00639316

P. Simeone, M. Trerotola, J. Franck, T. Cardon, M. Marchisio et al., The multiverse nature of epithelial to mesenchymal transition, Seminars in Cancer Biology, vol.58, pp.1-10, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02940760

D. Vergara, P. Simeone, M. Damato, M. Maffia, P. Lanuti et al., The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression, Journal of Oncology, vol.2019, pp.1-16, 2019.

M. J. Oliveira, A. M. Costa, A. C. Costa, R. M. Ferreira, P. Sampaio et al., CagA Associates with c?Met, E?Cadherin, and p120?Catenin in a Multiproteic Complex That SuppressesHelicobacter pylori?Induced Cell?Invasive Phenotype, The Journal of Infectious Diseases, vol.200, issue.5, pp.745-755, 2009.

L. E. Wroblewski, M. B. Piazuelo, R. Chaturvedi, M. Schumacher, E. Aihara et al., Helicobacter pyloritargets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells, Gut, vol.64, issue.5, pp.720-730, 2014.

T. Oda, Y. Kanai, T. Oyama, K. Yoshiura, Y. Shimoyama et al., E-cadherin gene mutations in human gastric carcinoma cell lines., Proceedings of the National Academy of Sciences, vol.91, issue.5, pp.1858-1862, 1994.

C. Vandewalle, F. Van-roy, and G. Berx, The role of the ZEB family of transcription factors in development and disease, Cellular and Molecular Life Sciences, vol.66, issue.5, pp.773-787, 2008.

T. Murai, S. Yamada, B. C. Fuchs, T. Fujii, G. Nakayama et al., Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer, Journal of Surgical Oncology, vol.109, issue.7, pp.684-689, 2014.

S. Brabletz and T. Brabletz, The ZEB/miR?200 feedback loop?a motor of cellular plasticity in development and cancer?, EMBO reports, vol.11, issue.9, pp.670-677, 2010.

W. Lehmann, D. Mossmann, J. Kleemann, K. Mock, C. Meisinger et al., ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types, Nature Communications, vol.7, issue.1, 2016.

Y. Liu, Y. Xin, F. Ye, W. Wang, Q. Lu et al., Taz-Tead1 Links Cell-Cell Contact to Zeb1 Expression, Proliferation, and Dedifferentiation in Retinal Pigment Epithelial Cells, Investigative Opthalmology & Visual Science, vol.51, issue.7, p.3372, 2010.

D. Vergara, S. Ravaioli, E. Fonzi, L. Adamo, M. Damato et al., Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling, International Journal of Molecular Sciences, vol.21, issue.3, p.715, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02941786

G. Posselt, M. Wiesauer, B. E. Chichirau, D. Engler, L. M. Krisch et al., Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis, Cell Communication and Signaling, vol.17, issue.1, 2019.

E. J. Jang, H. Jeong, K. H. Han, H. M. Kwon, J. Hong et al., TAZ Suppresses NFAT5 Activity through Tyrosine Phosphorylation, Molecular and Cellular Biology, vol.32, issue.24, pp.4925-4932, 2012.

E. Remue, K. Meerschaert, T. Oka, C. Boucherie, J. Vandekerckhove et al., TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner, FEBS Letters, vol.584, issue.19, pp.4175-4180, 2010.

T. A. Nagy, M. R. Frey, F. Yan, D. A. Israel, D. B. Polk et al., Helicobacter pyloriRegulates Cellular Migration and Apoptosis by Activation of Phosphatidylinositol 3-Kinase Signaling, Journal of Infectious Diseases, vol.199, issue.5, pp.641-651, 2009.

T. A. Nagy, L. E. Wroblewski, D. Wang, M. B. Piazuelo, A. Delgado et al., ?-Catenin and p120 Mediate PPAR?-Dependent Proliferation Induced by Helicobacter pylori in Human and Rodent Epithelia, Gastroenterology, vol.141, issue.2, pp.553-564, 2011.

N. Murata-kamiya, Y. Kurashima, Y. Teishikata, Y. Yamahashi, Y. Saito et al., Helicobacter pylori CagA interacts with E-cadherin and deregulates the ?-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells, Oncogene, vol.26, issue.32, pp.4617-4626, 2007.

A. T. Franco, D. A. Israel, M. K. Washington, U. Krishna, J. G. Fox et al., Activation of -catenin by carcinogenic Helicobacter pylori, Proceedings of the National Academy of Sciences, vol.102, issue.30, pp.10646-10651, 2005.

, Figure 2?figure supplement 1. Representative images used in the experiment, sampled from http://commons.wikimedia.org/wiki/Main_Page under the Creative Commons Attribution 4.0 International Public License https://creativecommons.org/licenses/by/4.0/., © 2020 by the authors. Licensee MDPI